58.17 +0.27 (0.47%)
WPI
| Trade WPI now with |
Stock Details
Last Trade:58.17 Change:+0.27 (0.47%) Prev Close:57.90 Open: 58.00 Days Range:57.35 – 58.26 52 Week Range: 53.73 - 73.35 Volume:667665 P/E: 39.84EPS:1.46
View AllRecent Alerts 02/09/12
Recent Alert on 02/08/12 at 8:30am
Watson (WPI) reaches settlement with Janssen Pharma related to ORTHO TRI-CYCLEN(R) LO
Watson (WPI) reaches settlement with Janssen Pharma related to ORTHO TRI-CYCLEN(R) LO
Watson (NYSE: WPI) reaches settlement with Janssen Pharma related to ORTHO TRI-CYCLEN(R) LO
Recent Alert on 02/08/12 at 8:30am
Watson (WPI) reaches settlement with Janssen Pharma related to ORTHO TRI-CYCLEN(R) LO
Watson (WPI) reaches settlement with Janssen Pharma related to ORTHO TRI-CYCLEN(R) LO
Recent Alert on 02/06/12 at 9:29am
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Q4/11 Preview: Post-2012 Message a Growing Focus: WPI and IPXL Top Ideas
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Q4/11 Preview: Post-2012 Message a Growing Focus: WPI and IPXL Top Ideas
Recent Alert on 02/03/12 at 9:27am
Watson Pharma (WPI) Says Generic Lidoderm ANDA 'On Track'; Will Not Comment Further
Watson Pharma (WPI) Says Generic Lidoderm ANDA 'On Track'; Will Not Comment Further
Recent Alert on 02/03/12 at 9:27am
Watson Pharma (WPI) Says Generic Lidoderm ANDA 'On Track'; Will Not Comment Further
Watson Pharma (WPI) Says Generic Lidoderm ANDA 'On Track'; Will Not Comment Further
View AllRecent Press Releases
Press Release on 02/08/12 at 8:30am
Watson Reaches Settlement With Janssen Pharmaceuticals, Inc. Over ORTHO TRI-CYCLEN(R) LO
Watson Reaches Settlement With Janssen Pharmaceuticals, Inc. Over ORTHO TRI-CYCLEN(R) LO
Press Release on 02/06/12 at 4:15pm
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULESĀ®
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULESĀ®
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 02/07/12 at 4:30pm
3 S&P 500 Companies Undervalued By EPS Trends Reporting Earnings Next Week
3 S&P 500 Companies Undervalued By EPS Trends Reporting Earnings Next Week


